Processing

Please wait...

Settings

Settings

Goto Application

1. MYPI 2014001998 - ORAL PHARMACEUTICAL COMPOSITION

Office
Malaysia
Application Number PI 2014001998
Application Date 14.02.2013
Publication Number PI 2014001998
Publication Date 18.02.2016
Publication Kind A
IPC
A61K 47/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen
10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols ; Poloxamers; PEG/POE alkyl ethers
A61K 31/7072
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7052having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
706containing six-membered rings with nitrogen as a ring hetero atom
7064containing condensed or non-condensed pyrimidines
7068having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
7072having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
A61K 31/513
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
513having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K 9/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
28Dragees; Coated pills or tablets
A61K 9/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
Applicants TAIHO PHARMACEUTICAL CO., LTD.
Inventors OGATA, TETSUO
OHNISHI, YOSHITO
Agents OON YEN YEN*
Priority Data 2012-031144 15.02.2012 JP
Title
(EN) ORAL PHARMACEUTICAL COMPOSITION
Abstract
(EN) THE PRESENT INVENTION PROVIDES AN FTD AND TPI-CONTAINING ORAL PHARMACEUTICAL COMPOSITION WHICH CAN BE ORALLY ADMINISTERED AND IS STABLE EVEN UNDER HIGH HUMIDITY CONDITIONS. AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING a, a, a-TRIFLUOROTHYMIDINE AND 5-CHLORO-6-(2-IMINOPYRROLIDINE-L-YL)METHYL-2, 4 (1H, 3H)-PYRIMIDINE DIONE HYDROCHLORIDE AS AN ACTIVE INGREDIENT; AND BEING SUBSTANTIALLY FREE OF AN ADDITIVE COMPRISING A METAL SALT.